I find it interesting that people are prepare to put enormous valuations on unproven biotechnology companies with potential someway into the future. Vision is already profitable and is gearing up to deliver more - and is priced below the likes of MBP. The high $A hurt it this half. Currently being valued as a no growth stock - worth buying for the income alone!